Previous 10 | Next 10 |
If you’re trying to make sense of the stock market today, you’re not alone. July Fed meeting minutes came out. Though they echoed a somewhat dovish tone, investors took caution as the first move with the S&P, Dow, and Nasdaq all retreating from their recent highs. With mor...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stock Mind Medicine (NASDAQ: MNMD ) stock nearly doubled overnight on rumors of a short squeeze. Shares that opened at 68 cents early on Aug. 17 were trading at $1.16 before the market opened on Aug. 18, after...
MindMed, which is up 71% in Thursday premarket trading, appears to be the latest beneficiary of the meme stock craze. The company, which is developing psychedelic drug treatments, closed up 10% Wednesday. A recent story in the Financial Times about US college s...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com It’s time to take a look at the biggest pre-market stock movers for Thursday and the news moving those shares! We’ve got a research grant, earnings reports, public ...
Top Penny Stocks To Buy Penny stocks are defined as shares of companies that trade for less than $5. But when you look at the “real” penny stocks, many traders will tell you to look for stocks trading for pennies. Today, we look at a handful of penny stocks to buy for ...
A unique stock even among the many distinctive titles that make up the biotech sector, Mind Medicine (NASDAQ: MNMD) reported its second-quarter results after market hours on Thursday. This followed the publication earlier that day of a "value enhancement plan" from a onetime top off...
After the market closed on Thursday, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results for the quarter ending June 30, 2022 . At this time the company has no revenue and reported a net loss of $17.1 million versus $44.5 million for the same...
MindMed Strengthens Board with Appointment of Two New Independent Directors Canada NewsWire NEW YORK , Aug. 12, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company"), a clinical stage biopharmaceutical company developing novel pr...
Mind Medicine (MindMed) Inc. (MNMD) Q2 2022 Results Conference Call August 11, 2022 04:30 PM ET Company Participants Robert Barrow - Chief Executive Officer Schond Greenway - Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fit...
MindMed Co-Founder Dr. Scott Freeman Proposes Value Enhancement Plan Canada NewsWire SHERIDAN, Wyo. , Aug. 11, 2022 /CNW/ -- Today, FCM MM HOLDINGS, LLC ("FCM") announced that it has sent a letter to the Board of Directors of Mind Medicine (MindMed) Inc. ...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
2024-07-26 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...